OCEA has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
OCEA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Ocean Biomedical's EBIT per Share for the three months ended in Sep. 2023 was $-0.52. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $-3.40.
During the past 3 years, the average EBIT per Share Growth Rate was -83.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Ocean Biomedical's EBIT per Share or its related term are showing as below:
During the past 4 years, the highest 3-Year average EBIT per Share Growth Rate of Ocean Biomedical was -83.50% per year. The lowest was -83.50% per year. And the median was -83.50% per year.
Ocean Biomedical's EBIT for the three months ended in Sep. 2023 was $-13.79 Mil.
The historical data trend for Ocean Biomedical's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ocean Biomedical Annual Data | |||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | |||||
EBIT per Share | -0.01 | -0.08 | -3.09 | -0.03 |
Ocean Biomedical Quarterly Data | |||||||||||||||
Dec19 | Mar20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | |
EBIT per Share | Get a 7-Day Free Trial | -0.18 | 0.42 | -2.89 | -0.41 | -0.52 |
EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.
Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.
Ocean Biomedical's EBIT per Share for the fiscal year that ended in Dec. 2022 is calculated as
EBIT per Share | (A: Dec. 2022 ) | ||
= | EBIT | / | Shares Outstanding (Diluted Average) | = | -0.958 | / | 36.496 |
= | -0.03 |
Ocean Biomedical's EBIT per Share for the quarter that ended in Sep. 2023 is calculated as
EBIT per Share | (Q: Sep. 2023 ) | ||
= | EBIT | / | Shares Outstanding (Diluted Average) | = | -13.794 | / | 26.605 |
= | -0.52 |
EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.40
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ocean Biomedical (NAS:OCEA) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Thank you for viewing the detailed overview of Ocean Biomedical's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Robert J Sweeney | officer: Chief Accounting Officer | 20298 CRAIGEN CIRCLE, SARATOGA CA 95070 |
M Michelle Berrey | director | 303A COLLEGE ROAD EAST, PRINCETON NJ 08450 |
William F Owens | director | C/O KEY ENERGY SERVICES, INC., 1301 MCKINNEY STREET, SUITE 1800, HOUSTON TX 77010 |
Inderjote S Kathuria | officer: Chief Strategy Officer | 19W060 AVENUE LATOUR, OAK BROOK IL 60523 |
Gurinder S Kalra | officer: Chief Financial Officer | 2305 WASHINGTON STREET, APT 301, SAN FRANCISCO CA 94115 |
Chirinjeev Kathuria | director | C/O UPHEALTH HOLDINGS, INC., 14000 S. MILITARY TRAIL #203, DELRAY BEACH FL 33484 |
Jerome Ringo | director | 1731 EMBARCADERO ROAD SUITE 200, PALO ALTO CA 94303 |
Poseidon Bio, Llc | 10 percent owner | OCEAN BIOMEDICAL, INC., 55 CLAVERICK ST., ROOM 325, PROVIDENCE RI 02903 |
Daniel Behr | officer: EVP, Innov./Acad. P'ships Head | OCEAN BIOMEDICAL, INC., 55 CLAVERICK ST., ROOM 325, PROVIDENCE RI 02903 |
Jack A Elias | director | OCEAN BIOMEDICAL, INC., 55 CLAVERICK ST., ROOM 325, PROVIDENCE RI 02903 |
Jonathan Kurtis | director | OCEAN BIOMEDICAL, INC., 55 CLAVERICK ST., ROOM 325, PROVIDENCE RI 02903 |
Elizabeth Ng | director, officer: Chief Executive Officer | OCEAN BIOMEDICAL, INC., 55 CLAVERICK ST., ROOM 325, PROVIDENCE RI 02903 |
Martin D Angle | director | OCEAN BIOMEDICAL, INC., 55 CLAVERICK ST., ROOM 325, PROVIDENCE RI 02903 |
Aesther Healthcare Sponsor, Llc | 10 percent owner | 515 MADISON AVE., SUITE 8078, NEW YORK NY 10022 |
Michael L Peterson | director | 17 CANARY COURT, DANVILLE CA 94526 |
From GuruFocus
By Marketwired • 08-29-2023
By GlobeNewswire • 10-04-2023
By sperokesalga sperokesalga • 06-01-2023
By Marketwired • 10-03-2023
By Marketwired • 08-01-2023
By Marketwired • 10-24-2023
By Marketwired • 06-23-2023
By Marketwired • 07-11-2023
By Marketwired • 10-04-2023
By sperokesalga sperokesalga • 05-25-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.